A study in Current Microbiology found higher antibiotic resistance genes in the noses and throats of Covid-19 patients. The ...

Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus ...

The US Food and Drug Administration approved updated Covid-19 vaccines Wednesday, but for a limited group: adults 65 and older, and younger people who are at higher risk from Covid-19. “FDA has now ...

Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...

School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research led by Oxford ...

The US Food and Drug Administration (FDA) has green-lit updated COVID-19 vaccines for the 2025–26 season for select groups, but confusion is already mounting over how physicians and insurers will ...

The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

Although the COVID-19 pandemic has largely subsided, scientists continue to investigate why the virus proved so deadly, ...

Traces of the pandemic are still plenty present in the Bayou City.

Fever, cough, sore throat and body aches can point to either COVID-19 or seasonal influenza, making it difficult to tell the ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. This voice experience is generated by AI. Learn more. This voice ...